Cafepharma Today

June 12 2025 - BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
Medtronic recalls ventilators linked to 2 serious injuries, 1 death
Merck aims to plug dengue fever vaccine gap in US
RFK Jr. names some vaccine critics to key CDC committee after ousting entire panel
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Health-Care False Claims Cases Reap $18.3 Billion, Report
Bloomberg
Tuesday, October 22, 2013 - 8:10am
tags:
whistleblower lawsuits, False Claims Act
Illumina reports eighth beat in a row, raises profit forecast
Yahoo/Reuters
Tuesday, October 22, 2013 - 8:08am
tags:
earnings, Illumina
Medivation, Astellas prostate cancer drug meets trial goals
Yahoo/Reuters
Tuesday, October 22, 2013 - 8:07am
tags:
Medivation, prostate cancer, Astellas, Enzalutamide
Novartis advances rival CDK 4/6 cancer drug to Pfizer's palbociclib
Fierce Biotech
Monday, October 21, 2013 - 5:55pm
tags:
Novartis, cyclin-dependent kinase inhibition [CDK], Pfizer, palbociclib, LEE011
Depomed Sells Type 2 Diabetes Royalties And Milestones To PDL BioPharma For $240.5 Million
Yahoo
Monday, October 21, 2013 - 5:51pm
tags:
diabetes, Depomed, PDL Biopharma
Will Celgene's (CELG) Earnings Streak End?
Yahoo/Zacks
Monday, October 21, 2013 - 5:50pm
tags:
Celgene, earnings
Ending drug trial secrecy is a boon for R&D, says EU agency
Yahoo/Reuters
Monday, October 21, 2013 - 5:49pm
tags:
clinical trial data, R&D
Is Amarin Going Belly-Up?
Seeking Alpha
Monday, October 21, 2013 - 4:16pm
tags:
Amarin, FDA, Vascepa
OncoMed presents data from trials of four anti-CSC therapeutics
The Fly on the Wall
Monday, October 21, 2013 - 4:14pm
tags:
OncoMed, anti-CSC
3 Red Flags for This Biotech IPO
Motley Fool
Monday, October 21, 2013 - 4:13pm
tags:
Intrexon, IPOs
Lilly's Lechleiter isn't budging from stand-alone $5B R&D strategy--yet
Fierce Biotech
Monday, October 21, 2013 - 11:55am
tags:
John Lechleiter, R&D, Eli Lilly
Earnings for C.R. Bard Expected to Fall
Forbes
Monday, October 21, 2013 - 11:54am
tags:
CR Bard, earnings, devices
Anticipated Earnings Increase for Bristol-Myers Squibb
Forbes
Monday, October 21, 2013 - 11:52am
tags:
Bristol-Myers Squibb, earnings
Can Eli Lilly Earnings Keep Up With Merck and Pfizer?
Motley Fool
Monday, October 21, 2013 - 11:52am
tags:
Eli Lilly, earnings, Merck, Pfizer
Catalyst Pharmaceuticals And Their Business Plan
Seeking Alpha
Monday, October 21, 2013 - 11:51am
tags:
Catalyst Pharmaceutical Partners, Biomarin, Biogen Idec, Firdapse, Lambert-Eaton myasthenic syndrome
Medtronic launches Export Advance catheter in the U.S.
Mass Device
Monday, October 21, 2013 - 10:08am
tags:
Medtronic, devices, Export Advance, aspiration catheter
VC funding follows tepid pace in Q3 as first-time biotech rounds shrivel
Fierce Biotech
Monday, October 21, 2013 - 10:06am
tags:
venture capital, biotech
GSK/Genmab file Arzerra for first-line CLL
Pharma Times, UK
Monday, October 21, 2013 - 9:56am
tags:
Arzerra, GSK, Genmab, CLL, chronic lymphocytic leukemia
Bristol-Myers Researcher Falsified Data In Grants And PhD Thesis
Pharmalot
Monday, October 21, 2013 - 9:55am
tags:
Bristol-Myers Squibb, R&D
Universities Stepping Up Efforts To Discover Drugs
Forbes
Monday, October 21, 2013 - 9:32am
tags:
R&D, Eli Lilly, Academic Drug Discovery Consortium, ADDC

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.